Daxxify Cost: Pricing, How It Compares to Botox, and Is It Worth It?

What does a Botox alternative that lasts nearly twice as long actually cost — and is the price premium justified? That’s the question driving most Daxxify consultations right now.

Daxxify (daxibotulinumtoxinA-lanm) received FDA approval in 2022, making it the first new neuromodulator approved in the US since Botox’s approval in 2002. Revance Therapeutics markets it as lasting 6 months on average — and in clinical trials, some patients saw results extend to 9 months. Standard Botox typically lasts 3–4 months. That durability difference is the entire value proposition.

Here’s what it costs and where the math actually works in your favor.

Daxxify pricing overview

How Daxxify pricing works

Unlike Botox, which is almost universally priced per unit, Daxxify is typically priced per treatment area or per vial. This is partly because Daxxify doesn’t map cleanly onto the same unit framework as Botox — it uses a different protein carrier (a peptide instead of albumin) and a different dosing paradigm.

Most practices price it as a flat area fee. Some charge per vial ($500–$800/vial), and a single vial covers most standard treatment areas.

This per-area pricing can actually simplify comparison shopping, but it also makes it harder to audit exactly what you’re getting. Always ask: how many injection sites, and what’s the dose per area?

Who is Daxxify FDA-approved for?

The FDA approved Daxxify specifically for glabellar lines (the vertical frown lines between the brows). That’s the only on-label indication. Providers use it off-label for forehead lines, crow’s feet, and other areas — just as they do with Botox — but the clinical trial data on duration refers specifically to glabellar lines.

In the pivotal SAKURA trials published in 2022, 80% of Daxxify patients maintained a response at 6 months compared to 67% for Botox. At 9 months, 23% of Daxxify patients still showed a meaningful response.

What affects Daxxify pricing

Practice type: Medical spas charge somewhat less than plastic surgeon offices. However, Daxxify is a newer product and not every practice carries it — availability affects price.

Geographic location: Practices in coastal metro areas price 25–50% above the national midpoint. A $650 glabellar treatment in Atlanta might run $950 in San Francisco.

Injector experience with Daxxify: Because the dosing differs from Botox (Daxxify doses are typically expressed in different units and don’t convert 1:1), injectors with limited Daxxify experience may under- or over-dose. Choose someone who’s been using it for at least 12–18 months.

Combination treatments: Many providers offer package pricing when combining Daxxify with filler or other treatments — sometimes 10–15% off per treatment.

Is Daxxify available everywhere?

Not yet. As of 2025, Daxxify distribution is expanding but it’s not stocked at every practice the way Botox is. Revance has been selective about its provider network. If your usual injector doesn’t carry it, you may need to seek out a different practice for your first treatment.

Common questions about Daxxify pricing

Does insurance cover it? No. Daxxify is purely cosmetic — no coverage.

Can I use CareCredit or Alphaeon Credit? Many practices accept medical financing for Daxxify. It’s worth asking if you want to spread the cost over monthly payments, especially for first-time higher-priced treatments.

What if the results don’t last as advertised? This is a real concern. In clinical trials, duration varied significantly by patient. Some people metabolize neuromodulators faster than others. If you try Daxxify and it lasts only 3–4 months (comparable to Botox), the higher per-treatment cost doesn’t pencil out. You may need to try Botox, Dysport, or Xeomin instead.

Is it safe? Yes — Daxxify uses the same botulinum toxin type A as Botox and has a similar safety profile based on FDA trial data. The peptide excipient instead of albumin is the primary formulation difference, which may appeal to patients avoiding albumin for personal or religious reasons.

The verdict on value

Daxxify makes the most financial sense for patients who:

• Currently get Botox every 3 months without exception
• Want fewer appointment-keeping commitments
• Are comfortable paying a higher per-visit fee for reduced annual frequency

It makes less sense if you’re a Botox “slow metabolizer” already getting 4–5 months of results, or if you’ve never tried a neuromodulator before and don’t know your response profile yet.

Bottom line: Daxxify typically costs $700–$1,600 for a full upper face treatment — roughly 50–75% more than Botox per session. Whether that’s worth it depends entirely on whether you actually achieve the promised 6+ month duration, which varies by patient. Try it once before committing to it as your regular neuromodulator.